Emergency Medicine Hub / Hematology & Oncology • 3 min read • 3 sections

Transfusion Medicine, Massive Transfusion & Coagulopathy Reversal

Comprehensive emergency protocol for massive hemorrhage resuscitation, acute transfusion reactions, and emergency anticoagulant reversal. Covers 1:1:1 balanced blood product resuscitation, prevention of the lethal trauma triad, early Tranexamic Acid (TXA), ionized calcium management, bedside differentiation of TRALI vs. TACO, and targeted reversal of Warfarin, direct Factor Xa inhibitors, and direct thrombin inhibitors.

Resuscitation Quick Actions • First 2 Minutes

High-Acuity

MTP Balanced Ratio

1:1:1 Ratio (1 unit PRBC : 1 unit FFP : 1 unit Platelets); prevents dilution coagulopathy

TXA Golden Window

Tranexamic Acid 1g IV bolus over 10 min within 3 hours of injury, followed by 1g IV over 8h (CRASH-2)

Citrate Toxicity & Calcium

Administer 1g Calcium Chloride IV (via central line) or 3g Calcium Gluconate IV for every 4 units of PRBC

Warfarin Life-Threatening Bleed

4-Factor PCC (Kcentra) 25-50 units/kg IV based on INR + Vitamin K1 10 mg IV slow push over 30 min

TRALI vs TACO

TRALI: Hypotension + Fever + Normal BNP + Bilateral non-cardiogenic infiltrates. TACO: Hypertension + Elevated BNP + Cardiogenic edema

Bottom-Line Clinical Pearl

In massive hemorrhage, activate the Massive Transfusion Protocol (MTP) immediately with a balanced 1:1:1 ratio of Packed Red Blood Cells (PRBC), Fresh Frozen Plasma (FFP), and Platelets. Administer IV Tranexamic Acid (1g bolus within 3 hours of injury) and aggressively replace ionized calcium (1g Calcium Chloride per 4 units PRBC to counter citrate intoxication). In life-threatening DOAC bleeding, administer Andexanet alfa or 4-Factor PCC for Factor Xa inhibitors, and Idarucizumab for Dabigatran.

1. Massive Transfusion Protocol (MTP) & Damage Control Resuscitation

Massive transfusion is traditionally defined as the transfusion of >= 10 units of packed red blood cells (PRBC) in 24 hours, or > 4 units in 1 hour with ongoing bleeding. Activation of an institutional MTP halts the Lethal Triad of Trauma (Hypothermia, Acidosis, and Coagulopathy) by delivering pre-thawed blood products in an anatomic, balanced physiological ratio:

Component/Step	Clinical Target & Ratio	Physiological Pearl & Management
Balanced Hemostatic Resuscitation	1:1:1 Ratio (6 units PRBC : 6 units FFP : 1 apheresis pack Platelets)	The PROPPR trial demonstrated that 1:1:1 resuscitation achieves significantly faster hemostasis and reduces death from exsanguination at 24 hours compared to 1:1:2 ratios. Minimizes crystalloid hemodilution and consumptive coagulopathy.
Tranexamic Acid (TXA)	1 gram IV bolus over 10 minutes, followed by 1 gram IV infusion over 8 hours.	The 3-Hour Golden Rule: Must be administered WITHIN 3 HOURS of traumatic injury (CRASH-2 trial). When given within 3 hours, TXA reduces all-cause mortality and bleeding death by 30%. Administration after 3 hours increases mortality due to vascular thrombosis.
Ionized Calcium & Citrate Intoxication	Target Ionized Calcium > 1.1 to 1.2 mmol/L. Administer 1g Calcium Chloride IV (or 3g Calcium Gluconate IV) for every 4 units of PRBC/FFP transfused.	Blood preservatives contain sodium citrate to chelate calcium and prevent clotting in storage. Rapid transfusion floods the liver with citrate, causing profound hypocalcemia, myocardial depression, refractory vasodilatory shock, and loss of the enzymatic clotting cascade.
Fibrinogen Replacement	Target serum Fibrinogen > 150 to 200 mg/dL. Administer Cryoprecipitate (10-20 units) or Fibrinogen Concentrate (2-4 grams IV).	Fibrinogen is the first coagulation factor to reach critically low levels during massive hemorrhage. Standard FFP contains relatively low concentrations of fibrinogen.

2. Acute Transfusion Reactions: TRALI vs. TACO Differentiation

Transfusion-Related Acute Lung Injury (TRALI) and Transfusion-Associated Circulatory Overload (TACO) are the leading causes of transfusion-related mortality. Both present with acute respiratory distress, hypoxemia, and bilateral pulmonary infiltrates within 6 hours of transfusion, but require opposite therapeutic strategies:

Diagnostic Feature	TRALI (Transfusion-Related Acute Lung Injury)	TACO (Transfusion-Associated Circulatory Overload)
Underlying Pathophysiology	Non-Cardiogenic Pulmonary Edema (ARDS variant): Donor anti-HLA or anti-neutrophil antibodies bind to recipient neutrophils sequestered in pulmonary capillaries, triggering capillary leak and microvascular destruction.	Cardiogenic Hydrostatic Pulmonary Edema: Excessive volume or rapid infusion rate exceeds the cardiac compliant capacity, driving hydrostatic fluid transudation into alveolar spaces.
Hemodynamic Profile	Hypotension (distributive/capillary leak); core temperature elevated (fever in > 70%).	Hypertension (SBP typically increases by > 30-50 mmHg); tachycardia; core temperature normal (afebrile).
Physical Examination	Normal jugular venous pressure (no JVD); absence of S3 gallop; pink frothy tracheal secretions.	Marked Jugular Venous Distension (JVD), peripheral pitting edema, S3 gallop, hepatojugular reflux.
Biomarkers & Echocardiography	Normal BNP/NT-proBNP; normal left ventricular ejection fraction; hyperdynamic cardiac function on POCUS; lung ultrasound demonstrates bilateral B-lines with normal LV filling pressures.	Markedly elevated BNP/NT-proBNP (typically > 1.5-fold increase over pre-transfusion); decreased LV ejection fraction; dilated IVC without respiratory collapse on POCUS.
Emergency Intervention	1. STOP TRANSFUSION IMMEDIATELY 2. Supportive lung-protective mechanical ventilation (ARDS protocol: low tidal volumes 6 mL/kg, PEEP) 3. Avoid aggressive diuresis (worsens hypotension) 4. Notify blood bank to quarantine donor products.	1. STOP TRANSFUSION IMMEDIATELY 2. Aggressive loop diuresis: Furosemide 40-80 mg IV 3. Non-Invasive Positive Pressure Ventilation (BiPAP/CPAP) 4. IV Nitroglycerin infusion to reduce preload and afterload.

3. Emergency Anticoagulant Reversal Protocols

Anticoagulant Class	Targeted Reversal Agent & Dosing	Secondary/Adjunctive Therapy	Monitoring & Clinical Rules
Warfarin (Coumadin) (Vitamin K Antagonist)	4-Factor Prothrombin Complex Concentrate (4F-PCC/Kcentra): - INR 2.0 to < 4.0: 25 units/kg IV (max 2,500 units) - INR 4.0 to 6.0: 35 units/kg IV (max 3,500 units) - INR > 6.0: 50 units/kg IV (max 5,000 units) Infuse over 10-15 minutes.	Vitamin K1 (Phytonadione) 10 mg IV in 50 mL D5W slow infusion over 30 minutes. (MANDATORY: 4F-PCC factors have a short half-life of 6-8 hours; Vitamin K stimulates endogenous hepatic factor synthesis to sustain reversal).	Re-check INR 30 minutes post-infusion; target INR < 1.4. Never use FFP if 4F-PCC is available (FFP takes hours to thaw, requires massive volume > 1.5-2 L, and carries high TACO/TRALI risk).
Direct Factor Xa Inhibitors (Apixaban [Eliquis], Rivaroxaban [Xarelto])	1. Andexanet Alfa (Andexxa): - Low Dose: 400 mg IV bolus at 30 mg/min, then 4 mg/min infusion x 120 min (if last dose < 8h ago and Eliquis <= 5mg/Xarelto <= 10mg) - High Dose: 800 mg IV bolus at 30 mg/min, then 8 mg/min x 120 min (if higher drug doses or unknown timing). OR 2. 4-Factor PCC 50 units/kg IV (max 5,000 units) if Andexanet is unavailable.	Activated Charcoal 50g PO if last ingestion occurred within 2 hours.	Targeted decoy protein: binds direct Xa inhibitors with high affinity. Rebound anti-Xa activity can occur 2 hours after infusion; monitor for thrombotic events.
Direct Thrombin Inhibitor (Dabigatran [Pradaxa])	Idarucizumab (Praxbind): 5.0 grams IV total, administered as two consecutive 2.5 gram IV bolus infusions over 5-10 minutes each.	Hemodialysis removes 60-70% of circulating dabigatran (low protein binding) if Idarucizumab is unavailable.	Humanized monoclonal antibody Fab fragment that binds dabigatran with 350x greater affinity than thrombin. Reverses aPTT and thrombin time instantaneously.
Unfractionated Heparin (UFH) & LMWH	Protamine Sulfate: - For UFH: 1 mg Protamine per 100 units of heparin received in past 2-3 hours (max 50 mg IV; administer slow push over 10 min). - For Enoxaparin (Lovenox): 1 mg Protamine per 1 mg Enoxaparin received in past 8 hours.	Monitor blood pressure: Rapid Protamine injection triggers severe hypotension and anaphylactoid shock. Neutralizes ~60% of anti-Xa activity of LMWH.	Target aPTT normalization.

TRALI vs. TACO: Opposing Resuscitation Traps

Administering high-dose loop diuretics to a patient with TRALI can precipitate fatal cardiovascular collapse by depleting intravascular volume in an already vasoplegic, capillary-leaking patient. Conversely, failing to aggressively diurese a patient in TACO will lead to asphyxiation from hydrostatic pulmonary edema. In patients developing respiratory distress during or within 6 hours of blood product transfusion: immediately stop the transfusion. Check blood pressure, JVD, and bedside echocardiography: if the patient is hypertensive with elevated BNP, JVD, and a dilated IVC, administer Furosemide (TACO); if the patient is hypotensive with fever, hyperdynamic cardiac function, and flat IVC, provide lung-protective ventilation and vasopressor support (TRALI).

Board & Shelf Drill 5 Questions • Untimed Tutor Mode

Test Your Transfusion Medicine, Massive Transfusion & Coagulopathy Reversal Clinical Acumen

Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.

Related Emergency Protocols & Differentials

Related EM Protocol